Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial

Auteurs

Jaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, Aurélie le Thuaut, Radj Gervais, Philippe Masson, Marie Marcq, Olivier Molinier, Alexis Cortot, Didier Debieuvre, Jacques Cadranel, Hervé Lena, Denis Moro-Sibilot, Christos Chouaid, Bertrand Mennecier, Thierry Urban, Christine Sagan, Ludivine Perrier, Fabrice Barlesi, Marc G. Denis